NDC - HCPCS Crosswalk

Effective October 1, 2018 through December 31, 2018

The crosswalk is intended to help understand which drug products -identified by NDCs- are assigned to which HCPCS billing codes. The crosswalk is not intended to be a comprehensive list of all NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units.

NDC HCPCS Code Labeler Drug Name Dosage Package Size Package Quantity Billable Units Billable Units / Pkg
50419-188-37A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML1551575
50419-188-38A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML20520100
50419-188-58A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML501050500
50419-188-81A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML5205100
50419-188-82A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML102010200
50419-188-83A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML152015300
50419-188-84A9579Bayer HealthCare Pharmaceuticals Inc.Gad-base mr contrast nos,1ml1 ML202020400
50419-320-05A9581Bayer HealthCare Pharmaceuticals Inc.Gadoxetate disodium inj1 ML1051050
50419-320-15A9581Bayer HealthCare Pharmaceuticals Inc.Gadoxetate disodium inj1 ML1551575
50419-325-11A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML7.520751500
50419-325-12A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML10201002000
50419-325-13A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML15201503000
50419-325-14A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML30103003000
50419-325-15A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML65106506500
50419-325-27A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML7.5575375
50419-325-28A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML105100500
50419-325-29A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML155150750
50419-325-37A9585Bayer HealthCare Pharmaceuticals Inc.Gadobutrol injection0.1 ML21520300
69488-001-40A9587Advanced Accelerator ApplicationsGallium Ga-680.1 mCi115454
17156-524-01A9600GE HealthcareSr89 strontiumPER MILLICURIE4144
11994-016-01A9604Lantheus Medical Imaging, Inc.Sm 153 lexidronamup to 150 millicuries3111
50419-208-01A9606Bayer HealthCare Pharmaceuticals Inc.Radium Ra223 dichloride ther1 mCi6111
68135-811-02C9014Biomarin Pharmaceutical, Inc.Injection, cerliponase alfa1 MG12150300
63833-828-02C9015CSL BehringC-1 esterase, Haegarda10 UNITS11200200
63833-829-02C9015CSL BehringC-1 esterase, Haegarda10 UNITS11300300
24338-150-20C9016Arbor PharmaceuticalsInj, triptorelin ext rel3.75 MG1166
68727-745-01C9024Jazz Pharmaceuticals Inc.Inj, daunorubicin-cytarabine1 MG/2.27 MG114444
68727-745-02C9024Jazz Pharmaceuticals, Inc.Inj, daunorubicin-cytarabine1 MG/2.27 MG124488
68727-745-05C9024Jazz Pharmaceuticals, Inc.Inj, daunorubicin-cytarabine1 MG/2.27 MG1544220
0008-0100-01C9028Pfizer Inc.Inj. inotuzumab ozogamicin0.1 MG1199
57894-640-01C9029Janssen Biotech, Inc.Injection, guselkumab1 MG11100100
50419-385-01C9030Bayer HealthCare Pharmaceuticals Inc.Inj copanlisib1 MG116060
69488-003-01C9031ADV. ACCELERATOR APPLICATION USAINCLutetium Lu 177 dotatate, tx1 MCI201200200
71394-415-01C9032SPARK THERAPEUTICS, INC.Voretigne neparvovec-rzyl1 EA0.51150150
69639-102-01C9033HELSINN THERAPEUTICS U.S.Inj, akynzeo0.25 MG1111
71879-001-01C9034EYEPOINT PHARMACEUTICALSInjection, dexamethasone 9%,1 MCG0.0051517517
63833-386-02C9132CSL BehringKcentra, per i.u.1 IU1111
63833-387-02C9132CSL BehringKcentra, per i.u.1 IU1111
0944-8503-02C9250Baxter Healthcare CorporationArtiss fibrin sealant2 ML1111
0944-8503-04C9250Baxter Healthcare CorporationArtiss fibrin sealant2 ML1122
0944-8503-10C9250Baxter Healthcare CorporationArtiss fibrin sealant2 ML1155
50242-060-01C9257Genentech, Inc.Bevacizumab injection0.25 MG41400400
50242-061-01C9257Genentech, Inc.Bevacizumab injection0.25 MG16116001600
50633-210-11C9293BTG InternationalInjection, glucarpidase 10 Units11100100
62225-600-04C9447OmerosInj, phenylephrine ketorolac4 ML4414
10122-620-10C9460Chiesi USA, Inc.Injection, cangrelor1 MG11050500
65293-003-10C9460The Medicines CompanyInjection, cangrelor1 MG11050500
70842-102-03C9462MELINTA THERAPEUTICSInjection, delafloxacin1 MG1103003000
47426-201-01C9463HERON THERAPEUTICS, INC.Injection, aprepitant1 MG181130130
69656-102-10C9464Tesaro Inc.Injection, rolapitant0.5 MG92.51333333
0310-1730-30C9466AstraZeneca Pharmaceuticals LPInjection, benralizumab1 MG113030
50242-108-01C9467Genentech, Inc.Inj rituximab hyaluronidase10 MG (rituximab)11.71140140
50242-109-01C9467Genentech, Inc.Inj rituximab hyaluronidase10 MG (rituximab)13.41160160
0169-7901-01C9468NOVO NORDISK, INC.Inj, factor ix, Rebinyn1 IU1111
0169-7902-01C9468NOVO NORDISK, INC.Inj, factor ix, Rebinyn1 IU1111
0169-7905-01C9468NOVO NORDISK, INC.Inj, factor ix, Rebinyn1 IU1111
69724-112-10C9482Altathera Pharmaceuticals LLCSotalol hydrochloride IV1MG101150150
66220-160-10C9488Cumberland Pharmaceuticals IncConivaptan HCL1 MG10012020
0310-4500-12C9492AstraZeneca Pharmaceuticals LPInjection, durvalumab10 MG2.411212
0310-4611-50C9492AstraZeneca Pharmaceuticals LPInjection, durvalumab10 MG1015050
Page 3